4.56
price down icon5.30%   -0.255
after-market 시간 외 거래: 4.58 0.02 +0.44%
loading
전일 마감가:
$4.815
열려 있는:
$4.75
하루 거래량:
4.42M
Relative Volume:
1.04
시가총액:
$1.09B
수익:
$251.85M
순이익/손실:
$-72.58M
주가수익비율:
-14.55
EPS:
-0.3134
순현금흐름:
$-63.80M
1주 성능:
-0.22%
1개월 성능:
-11.11%
6개월 성능:
-22.45%
1년 성능:
-29.63%
1일 변동 폭
Value
$4.54
$4.81
1주일 범위
Value
$4.505
$4.83
52주 변동 폭
Value
$4.02
$9.33

Ardelyx Inc Stock (ARDX) Company Profile

Name
명칭
Ardelyx Inc
Name
전화
510-745-7047
Name
주소
34175 ARDENWOOD BLVD., FREMONT, CA
Name
직원
395
Name
트위터
@ardelyx
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
ARDX's Discussions on Twitter

ARDX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ARDX
Ardelyx Inc
4.56 1.09B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-07 재개 Ladenburg Thalmann Buy
2025-03-04 개시 BTIG Research Buy
2024-11-11 다운그레이드 H.C. Wainwright Buy → Neutral
2024-07-02 다운그레이드 Piper Sandler Overweight → Neutral
2024-04-05 개시 Leerink Partners Outperform
2023-12-18 개시 Raymond James Strong Buy
2023-09-07 개시 H.C. Wainwright Buy
2023-08-25 업그레이드 Cantor Fitzgerald Neutral → Overweight
2023-03-03 업그레이드 Wedbush Neutral → Outperform
2022-11-17 업그레이드 Piper Sandler Neutral → Overweight
2022-05-06 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2021-12-01 업그레이드 Ladenburg Thalmann Neutral → Buy
2021-10-14 다운그레이드 Ladenburg Thalmann Buy → Neutral
2021-07-21 다운그레이드 Jefferies Buy → Hold
2021-07-20 다운그레이드 Piper Sandler Overweight → Neutral
2021-07-20 다운그레이드 Wedbush Outperform → Neutral
2021-03-23 개시 Wedbush Outperform
2021-01-06 개시 Cantor Fitzgerald Overweight
2020-10-20 재개 Citigroup Buy
2020-02-18 재개 Jefferies Buy
2020-02-12 개시 Citigroup Buy
2020-02-10 개시 Cowen Outperform
2019-04-08 개시 Piper Jaffray Overweight
2018-08-24 개시 Jefferies Buy
2018-03-19 재개 Leerink Partners Outperform
2017-11-29 재확인 Citigroup Buy
2017-11-22 재확인 Ladenburg Thalmann Buy
2017-10-17 재개 Leerink Partners Outperform
2016-03-31 개시 Ladenburg Thalmann Buy
2016-03-09 개시 Cantor Fitzgerald Buy
2016-03-03 개시 Citigroup Buy
모두보기

Ardelyx Inc 주식(ARDX)의 최신 뉴스

pulisher
Apr 19, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 19, 2025
pulisher
Apr 19, 2025

Lobbying Update: $620,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq

Apr 19, 2025
pulisher
Apr 17, 2025

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times

Apr 17, 2025
pulisher
Apr 17, 2025

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 | ARDX Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Ardelyx, Inc. Schedules Conference Call to Discuss Q1 2025 Financial Results and Business Update - Nasdaq

Apr 17, 2025
pulisher
Apr 16, 2025

Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

April 2025's Top Penny Stocks To Watch - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025
pulisher
Apr 15, 2025

Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call - The Globe and Mail

Apr 15, 2025
pulisher
Apr 10, 2025

Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Apr 10, 2025
pulisher
Apr 10, 2025

Ontario Teachers' Appoints Terry Hickey as Chief Technology Officer - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 08, 2025

Ardelyx CEO Michael Raab sells $191k in stock - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Ardelyx CEO Michael Raab sells $191k in stock By Investing.com - Investing.com UK

Apr 08, 2025
pulisher
Apr 07, 2025

Ardelyx stock hits 52-week low at $4.29 amid challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Ardelyx stock hits 52-week low at $4.29 amid challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 06, 2025

How To Trade (ARDX) - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 06, 2025

Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Apr 06, 2025
pulisher
Apr 03, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 02, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 01, 2025

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Apr 01, 2025
pulisher
Mar 31, 2025

First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq

Mar 31, 2025
pulisher
Mar 28, 2025

Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st

Mar 28, 2025
pulisher
Mar 27, 2025

How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 20, 2025

Ardelyx Requests to Dismiss Class Action Filed by Investors - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com

Mar 20, 2025
pulisher
Mar 19, 2025

ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025
pulisher
Mar 17, 2025

Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 17, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Five Champions of Kidney Disease Advocacy Receive Groundbreaking Ardelyx Recognition - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Insider Buying: David Mott Acquires Shares of Ardelyx Inc (ARDX) - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

8,020 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Bought by SBI Securities Co. Ltd. - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities - Investing.com India

Mar 11, 2025

Ardelyx Inc (ARDX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):